The role of NPC2 gene in glioma was investigated based on bioinformatics analysis
Authors:
Open Access
- 19 August 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-13
Abstract
Glioblastoma (GBM) is one of the most malignant primary brain tumors in adults. The NPC2 gene (Niemann–Pick type C intracellular cholesterol transporter 2) is a protein-coding gene with a lipid recognition domain. The NPC2 gene was found to be significantly increased in gliomas (LGG and GBM), and it is now thought to be a risk factor. COX analysis demonstrated that NPC2 was a significant risk factor for glioma. Functional enrichment analysis of genes that were differentially expressed between high and low expression groups revealed that genes were primarily enriched in the regulation of trans-synaptic signaling, Retrograde endocannabinoid signaling and other pathways. According to the findings of the immunoinfiltration investigation, the NPC2 gene and macrophage, DC, etc. have a strong positive association. In addition, patients with high NPC2 expression had higher levels of immune cell expression. Medication sensitivity research revealed that NPC2’s differential expression had some bearing on patients’ medication sensitivity. There was a strong correlation between the prognosis of glioma patients and the gene sets NUDT19 and NUME. In brief, the NPC2 gene was identified to be a possible biomarker of glioma, and preliminary analysis was done on the role of the NPC2 gene in immunological microenvironment of glioma.Keywords
All Related Versions
Funding Information
- Fujian Provincial Health Technology Project (No. 2021CXA009)
This publication has 29 references indexed in Scilit:
- Prognostic significance of high NPC2 expression in gastric cancerScientific Reports, 2023
- cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunityImmunity, 2023
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- The characteristics and biological significance of NPC2: Mutation and diseaseMutation Research - Reviews in Mutation Research, 2019
- Cellular and molecular mechanisms of glioblastoma malignancy: Implications in resistance and therapeutic strategiesSeminars in Cancer Biology, 2019
- Chemical Modulation of Human Mitochondrial ClpP: Potential Application in Cancer TherapeuticsACS Chemical Biology, 2019
- Glioblastoma Therapy in the Age of Molecular MedicineTrends in Cancer, 2019
- Multidimensional communication in the microenvirons of glioblastomaNature Reviews Neurology, 2018
- Current state of immunotherapy for glioblastomaNature Reviews Clinical Oncology, 2018
- Glioblastoma multiforme: Pathogenesis and treatmentPharmacology & Therapeutics, 2015